Cantargia AB is a biotechnology company based in Lund, Sweden, that develops antibody-based treatments for cancer. Its work centres on therapies that target a protein found on certain cancer cells and on the cells supporting tumours, aiming to help the body's immune system attack the disease. The company carries out research and clinical development of these drug candidates, working with partners and investigators in the oncology field.
Cantargia AB trades under the code CANTA on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #784 of 912 on the Nasdaq Stockholm · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendWeak
6/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-53.7%
From 52-week high-77.8%
MomentumWeak
11/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-26.7%
6-month return-64.5%
12-month, skipping last month-52.0%
Stability (higher is calmer)Weak
20/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)74.5%
Worst drawdown, 1 year (smaller is calmer)-79.3%
LiquidityFair
67/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.17M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 1.250 – 6.590Daily closes, split-adjusted
Signals
50-day average1.563
200-day average2.969
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.080
Technical summary
Daily
Bearish
4 bullish · 4 neutral · 8 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
1.34
Bullish
EMA 10
1.36
Bullish
SMA 20
1.37
Bullish
EMA 20
1.39
Bearish
SMA 50
1.56
Bearish
EMA 50
1.55
Bearish
SMA 100
1.76
Bearish
EMA 100
1.89
Bearish
SMA 200
2.97
Bearish
EMA 200
2.38
Bearish
Oscillators (daily)
RSI (14)
43.43
Neutral
MACD (12, 26)
-0.05
Bearish
Momentum (12)
0.29
Bullish
Stochastic %K (14)
50.41
Neutral
Williams %R (14)
-49.59
Neutral
CCI (20)
19.91
Neutral
Pivot points (classic, last session)
S3
1.24
S2
1.30
S1
1.34
Pivot
1.40
R1
1.44
R2
1.50
R3
1.54
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
